Evidence map›Paper›PMID 42514175›Full record

ArticleLife (Basel, Switzerland)2026

Abdominal Aorta Balloon Occlusion Versus Standard Care in Placenta Accreta Spectrum Disorder: A Randomized Controlled Trial.

Gauri Bapayeva, Meruyert Abdukassimova, Nazira Kadroldinova, Kuat Kassymbek, Karlygash Togyzbayeva, Lyazzat Saidildina, Viktor Zemlyanskiy, Kuanysh Balgynbayev, Mariya Usseyeva, Gulzhanat Aimagambetova and 1 more

Registry-linked trialAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Life (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06721182 (Effectiveness of Endovascular Balloon Occlusion of the Aorta in Reducing Blood Loss During Cesarean Section in Patients with Placenta Accreta Spectrum Disorders in Tertiary Care Center in Kazakhstan), which is not on this map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06721182 nanot yet recruitingnot on this map

Effectiveness of Endovascular Balloon Occlusion of the Aorta in Reducing Blood Loss During Cesarean Section in Patients with Placenta Accreta Spectrum Disorders in Tertiary Care Center in Kazakhstan: a Randomized Controlled Trial

TypeinterventionalSponsorNazarbayev UniversityRan2024 to 2026Enrolled100ConditionsPlacenta Accreta SpectrumArmsREBOA
3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Gauri BapayevaClinical Academic Department of Women's Health, Corporate Fund University Medical Center, Astana Z05G9F0, Kazakhstan.
Meruyert AbdukassimovaDepartment of Surgery, School of Medicine, Nazarbayev University, Astana Z05P3Y4, Kazakhstan.ORCID 0000-0001-9196-1496
Nazira KadroldinovaDepartment of Surgery, School of Medicine, Nazarbayev University, Astana Z05P3Y4, Kazakhstan.ORCID 0000-0003-4309-0432
Kuat KassymbekClinical Academic Department of Women's Health, Corporate Fund University Medical Center, Astana Z05G9F0, Kazakhstan.
Karlygash TogyzbayevaClinical Academic Department of Women's Health, Corporate Fund University Medical Center, Astana Z05G9F0, Kazakhstan.
Lyazzat SaidildinaClinical Academic Department of Women's Health, Corporate Fund University Medical Center, Astana Z05G9F0, Kazakhstan.
Viktor ZemlyanskiyClinical Academic Department of Radiology and Nuclear Medicine, Corporate Fund University Medical Center, Astana Z05G9F0, Kazakhstan.ORCID 0000-0002-2458-8086
Kuanysh BalgynbayevClinical Academic Department of Anaesthesiology and Intensive Care, Corporate Fund University Medical Center, Astana Z05G9F0, Kazakhstan.ORCID 0009-0003-6641-2366
Mariya UsseyevaClinical Academic Department of Pathology, Corporate Fund University Medical Center, Astana Z05G9F0, Kazakhstan.
Gulzhanat AimagambetovaClinical Academic Department of Women's Health, Corporate Fund University Medical Center, Astana Z05G9F0, Kazakhstan.ORCID 0000-0002-2868-4497
Milan TerzicClinical Academic Department of Women's Health, Corporate Fund University Medical Center, Astana Z05G9F0, Kazakhstan.ORCID 0000-0003-3914-5154

Funding

Science Committee of the Ministry of Science and Higher Education of the Republic of Kazakhstan No.AP23487763
6 · The paper itself

Abstract

Placenta accreta spectrum (PAS) is associated with substantial intraoperative hemorrhage. Abdominal aortic balloon occlusion (AABO) has been introduced to mitigate blood loss, though its benefit remains debated. This study, registered at ClinicalTrials.gov (NCT06721182), assessed maternal outcomes in women with PAS undergoing cesarean delivery managed either with abdominal aortic balloon occlusion or standard surgical care alone. The study (

Indexed as

abdominal aortic balloon occlusioncesarean deliveryhysterectomyobstetric hemorrhageplacenta accreta spectrum

Identifiers

PMID42514175
PMCPMC13413313

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.